Lorraine A. Todor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lorraine A. Todor has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- David M. Hill
Department of Pharmacy, Regional One Health , Memphis, TN 38103
5 shared publications - Allison N. Boyd
Department of Pharmacy, Eskenazi Health , Indianapolis, IN 46202
2 shared publications - Beatrice Adams
Department of Pharmacy, Tampa General Hospital , Tampa, FL 33606
2 shared publications Felix Pham
Department of Pharmacy, Torrance Memorial Medical Center , Torrance, CA 90505
2 shared publicationsJanie Faris
Department of Pharmacy, Parkland Health , Dallas, TX 75325
2 shared publicationsKaitlin M Alexander
Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy , Gainesville, FL 32608
2 shared publications
Latest Publications
- 21 October 2025
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 47 (2) , 490-499
An Appraisal of Pharmacotherapy-Pertinent Literature Published in 2023 and 2024 for Clinicians Caring for Patients with Thermal or Inhalation Injury
Pharmacotherapy interventions following thermal or inhalation injury remain an underrepresented area of focus in the literature, with studies dispersed across a broad array of journals. This review builds upon several years of previous efforts to highlight and summarize the most recent, quality pharmacotherapy-focused studies in the context of thermal and inhalation injuries. Twenty-five geographically dispersed, board-certified pharmacists participated in the review. A Medical Subject Heading-based, filtered search resulted in 2234 manuscripts over the previous 2-year period. After manual review, 78 (3.5%) manuscripts were determined to have a potential impact on current pharmacotherapy practice. Summaries of the 10 articles scored to have the highest impact are included in this review. There exists a continued need for high-impact research addressing pharmacotherapeutic strategies in the management of patients with thermal and inhalation injuries.
- 21 October 2025
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 47 (2) , 490-499
An Appraisal of Pharmacotherapy-Pertinent Literature Published in 2023 and 2024 for Clinicians Caring for Patients with Thermal or Inhalation Injury
Pharmacotherapy interventions following thermal or inhalation injury remain an underrepresented area of focus in the literature, with studies dispersed across a broad array of journals. This review builds upon several years of previous efforts to highlight and summarize the most recent, quality pharmacotherapy-focused studies in the context of thermal and inhalation injuries. Twenty-five geographically dispersed, board-certified pharmacists participated in the review. A Medical Subject Heading-based, filtered search resulted in 2234 manuscripts over the previous 2-year period. After manual review, 78 (3.5%) manuscripts were determined to have a potential impact on current pharmacotherapy practice. Summaries of the 10 articles scored to have the highest impact are included in this review. There exists a continued need for high-impact research addressing pharmacotherapeutic strategies in the management of patients with thermal and inhalation injuries.
- 20 May 2025
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
A Retrospective, Noninferiority Study of a Treat-at-Home Strategy Utilizing a Surfactant-based Dressing for Partial-Thickness Burn Wounds
Partial-thickness (PT) burns are the most common depth of burn seen in emergency departments (ED). This study aimed to evaluate the outcomes of patients managed with a treatment-at-home (TAH) strategy using water-soluble surfactant dressing (WSD) compared to any other dressing (non-WSD). This single-center, retrospective study included all patients with thermal burns treated in the burn center-specific ED between May 2019 and May 2023. Patients were excluded if admission was deemed necessary during the initial ED assessment. Additionally, patients were excluded for having first-degree burns, full-thickness burns, electrical burns, being less than 18 years old, pregnant or incarcerated, or not expected to survive. The planned enrollment was designed to fulfill noninferiority and potential superiority of surfactant-based dressing versus any other TAH strategy. Two-thousand seven-hundred forty-seven patients were screened over the 4-year study. After applying exclusion criteria, 1001 patients remained in the study group. There were no differences in demographics and injury mechanism, except the non-WSD group contained more patients that were cocaine positive (P = .009)and had burns to the head/neck (P < .0001). Few in the WSD or non-WSD group required subsequent admission for burn wound excision [5 (1.0%) vs 2 (0.4%)] although the non-WSD had significantly fewer return for follow-up [336 (68.71%) vs 273 (53.32%), P < .001]. This is the largest study to evaluate the use of WSD for immediate treatment of PT burns to avoid admission. WSD was found to be non-inferior to other non-WSD TAH strategies. But no matter the choice of home wound treatment, few required subsequent admission for surgery. Given the success of both groups, a TAH model, when feasible, could allow patients to recover at home and result in cost and resource savings associated with admission.
- 20 May 2025
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
A Retrospective, Noninferiority Study of a Treat-at-Home Strategy Utilizing a Surfactant-based Dressing for Partial-Thickness Burn Wounds
Partial-thickness (PT) burns are the most common depth of burn seen in emergency departments (ED). This study aimed to evaluate the outcomes of patients managed with a treatment-at-home (TAH) strategy using water-soluble surfactant dressing (WSD) compared to any other dressing (non-WSD). This single-center, retrospective study included all patients with thermal burns treated in the burn center-specific ED between May 2019 and May 2023. Patients were excluded if admission was deemed necessary during the initial ED assessment. Additionally, patients were excluded for having first-degree burns, full-thickness burns, electrical burns, being less than 18 years old, pregnant or incarcerated, or not expected to survive. The planned enrollment was designed to fulfill noninferiority and potential superiority of surfactant-based dressing versus any other TAH strategy. Two-thousand seven-hundred forty-seven patients were screened over the 4-year study. After applying exclusion criteria, 1001 patients remained in the study group. There were no differences in demographics and injury mechanism, except the non-WSD group contained more patients that were cocaine positive (P = .009)and had burns to the head/neck (P < .0001). Few in the WSD or non-WSD group required subsequent admission for burn wound excision [5 (1.0%) vs 2 (0.4%)] although the non-WSD had significantly fewer return for follow-up [336 (68.71%) vs 273 (53.32%), P < .001]. This is the largest study to evaluate the use of WSD for immediate treatment of PT burns to avoid admission. WSD was found to be non-inferior to other non-WSD TAH strategies. But no matter the choice of home wound treatment, few required subsequent admission for surgery. Given the success of both groups, a TAH model, when feasible, could allow patients to recover at home and result in cost and resource savings associated with admission.
- 19 July 2024
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 45 (5) , 1363-1364
Letter to the Editor: Multidrug-Resistant Organisms: The Silent Plight of Burn Patients
- 19 July 2024
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 45 (5) , 1363-1364
Letter to the Editor: Multidrug-Resistant Organisms: The Silent Plight of Burn Patients
- 20 April 2024
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 45 (5) , 1103-1109
Retrospective analysis of pathogens for guided creation of an EMPIRIc antibiotic prEscribing pathway (EMPIRE)
The objective of this study was to evaluate the susceptibilities of pathogens isolated from cultures within the first 7 days of admission to the burn center and in the absence of healthcare-associated infection risk factors (HAIRF) to determine if current empiric antibiotics can be narrowed for refinement of an empiric antibiotic prescribing pathway according to the suspected source. A 3-year sample of patients and cultures was utilized in hopes of obtaining at least 30 isolates of the most common pathogens and their respective susceptibilities. A total of 268 clinically relevant (e.g., deemed infectious, versus colonization) pathogens were included in the final sample with sources including wounds, respiratory, blood, urine, and bone. Of the 268 pathogens included, 45% were Gram-negative and 69% of all pathogens were isolated from wound cultures. The existing empiric pathway, vancomycin plus cefepime, covered 98% and 84% of all Gram-positive and Gram-negative pathogens, respectively. In patients without HAIRF, coverage rose to 98% and 90%, respectively. Initial use of vancomycin and cefepime remains adequate for pathogens isolated within 1 week of admission in patients without HAIRF. For pneumonias, a narrower spectrum beta-lactam would not sufficiently cover respiratory pathogens isolated within the first week of admission. Regarding early wound infections, difficult-to-treat pathogens remain as a rare isolate of wound cultures within 1 week of admission.
- 20 April 2024
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 45 (5) , 1103-1109
Retrospective analysis of pathogens for guided creation of an EMPIRIc antibiotic prEscribing pathway (EMPIRE)
The objective of this study was to evaluate the susceptibilities of pathogens isolated from cultures within the first 7 days of admission to the burn center and in the absence of healthcare-associated infection risk factors (HAIRF) to determine if current empiric antibiotics can be narrowed for refinement of an empiric antibiotic prescribing pathway according to the suspected source. A 3-year sample of patients and cultures was utilized in hopes of obtaining at least 30 isolates of the most common pathogens and their respective susceptibilities. A total of 268 clinically relevant (e.g., deemed infectious, versus colonization) pathogens were included in the final sample with sources including wounds, respiratory, blood, urine, and bone. Of the 268 pathogens included, 45% were Gram-negative and 69% of all pathogens were isolated from wound cultures. The existing empiric pathway, vancomycin plus cefepime, covered 98% and 84% of all Gram-positive and Gram-negative pathogens, respectively. In patients without HAIRF, coverage rose to 98% and 90%, respectively. Initial use of vancomycin and cefepime remains adequate for pathogens isolated within 1 week of admission in patients without HAIRF. For pneumonias, a narrower spectrum beta-lactam would not sufficiently cover respiratory pathogens isolated within the first week of admission. Regarding early wound infections, difficult-to-treat pathogens remain as a rare isolate of wound cultures within 1 week of admission.
- 29 January 2024
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 45 (3) , 614-624
An Appraisal of Pharmacotherapy-Pertinent Literature Published in 2021 and 2022 for Clinicians Caring for Patients With Thermal or Inhalation Injury
Studies focusing on pharmacotherapy interventions to aid patients after thermal injury are a minor focus in burn injury-centered studies and published across a wide array of journals, which challenges those with limited resources to keep their knowledge current. This review is a renewal of previous years’ work to facilitate extraction and review of the most recent pharmacotherapy-centric studies in patients with thermal and inhalation injury. Twenty-three geographically dispersed, board-certified pharmacists participated in the review. A Medical Subject Heading-based, filtered search returned 2336 manuscripts over the previous 2-year period. After manual review, 98 (4%) manuscripts were determined to have a potential impact on current pharmacotherapy practice. The top 10 scored manuscripts are discussed. Only 17% of those reviewed were assessed to likely have little effect on current practice. The overall impact of the current cohort was higher than previous editions of this review, which is encouraging. There remains a need for investment in well-designed, high-impact, pharmacotherapy-pertinent research for patients sustaining thermal or inhalation injuries.
- 29 January 2024
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 45 (3) , 614-624
An Appraisal of Pharmacotherapy-Pertinent Literature Published in 2021 and 2022 for Clinicians Caring for Patients With Thermal or Inhalation Injury
Studies focusing on pharmacotherapy interventions to aid patients after thermal injury are a minor focus in burn injury-centered studies and published across a wide array of journals, which challenges those with limited resources to keep their knowledge current. This review is a renewal of previous years’ work to facilitate extraction and review of the most recent pharmacotherapy-centric studies in patients with thermal and inhalation injury. Twenty-three geographically dispersed, board-certified pharmacists participated in the review. A Medical Subject Heading-based, filtered search returned 2336 manuscripts over the previous 2-year period. After manual review, 98 (4%) manuscripts were determined to have a potential impact on current pharmacotherapy practice. The top 10 scored manuscripts are discussed. Only 17% of those reviewed were assessed to likely have little effect on current practice. The overall impact of the current cohort was higher than previous editions of this review, which is encouraging. There remains a need for investment in well-designed, high-impact, pharmacotherapy-pertinent research for patients sustaining thermal or inhalation injuries.
- Open Access
- 3 June 2023
- Published by MDPI AG in Antibiotics
- Vol. 12 (6) , 1002
Deficiencies of Rule-Based Technology-Generated Antibiograms for Specialized Care Units
The objective of this study was to compare the pathogens and susceptibilities of the current automated, rule-based technology (RBT) antibiogram with one manually collected through chart review with additional rules applied. This study was a two-year, retrospective cohort study and included all bacterial cultures within the first 30 days from patients admitted to a single Burn Center. The current RBT antibiogram served as the control, and new antibiogram versions were created using additional rules and compared to the control. Six-hundred fifty-seven patients were admitted (61% excluded for lack of cultures). 59% had at least one hospital-acquired risk factor, with over one-third having recent illicit drug use and one-third having a recent hospitalization. Of the 410 cultures included, 57% were Gram-negative, and half were from wound infections. Sensitivities were significantly different when comparing the manual and the RBT version after including factors such as days since admission, presence of hospital-acquired risk factors, or previous antibiotic courses. Recommended empiric Gram-negative antibiotics changed from double coverage to a single β-lactam with >90% susceptibility. The susceptibilities between the first and subsequent courses were dramatically different. Before developing an antibiogram or interpreting the output, it is important to consider which automated criteria are utilized, especially for units with extended lengths of stay.
- 3 June 2023
- Published by MDPI AG in Antibiotics
- Vol. 12 (6) , 1002
Open AccessDeficiencies of Rule-Based Technology-Generated Antibiograms for Specialized Care Units
The objective of this study was to compare the pathogens and susceptibilities of the current automated, rule-based technology (RBT) antibiogram with one manually collected through chart review with additional rules applied. This study was a two-year, retrospective cohort study and included all bacterial cultures within the first 30 days from patients admitted to a single Burn Center. The current RBT antibiogram served as the control, and new antibiogram versions were created using additional rules and compared to the control. Six-hundred fifty-seven patients were admitted (61% excluded for lack of cultures). 59% had at least one hospital-acquired risk factor, with over one-third having recent illicit drug use and one-third having a recent hospitalization. Of the 410 cultures included, 57% were Gram-negative, and half were from wound infections. Sensitivities were significantly different when comparing the manual and the RBT version after including factors such as days since admission, presence of hospital-acquired risk factors, or previous antibiotic courses. Recommended empiric Gram-negative antibiotics changed from double coverage to a single β-lactam with >90% susceptibility. The susceptibilities between the first and subsequent courses were dramatically different. Before developing an antibiogram or interpreting the output, it is important to consider which automated criteria are utilized, especially for units with extended lengths of stay.